Product Image

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
4.7
★ ★ ★ ★ ★
(7094 ratings)
Ginkgo
Product Image
Score84
A practical ginkgo serving for circulation-related cognitive use. Both marker groups are named, but their percentages and a low-ginkgolic-acid standard are absent.
How scoring works
Quantity:180 Capsule(s) • (180 servings)
Goals:
Productivity Boost
Mental Focus
Brain Health
Cognitive Support
Vision Support

Score 84

A practical ginkgo serving for circulation-related cognitive use. Both marker groups are named, but their percentages and a low-ginkgolic-acid standard are absent.
How scoring works

Also available as

1 option
60 servings Ginkgo 120 mg • 60 Capsule(s) • 60 servings $11.67 ($0.19 per serving)
$23.00($0.12 per serving)
iHerb
$ 23.00
Report prices

Analysis

The capsule provides 120 mg ginkgo extract, targeting cerebral and peripheral circulation. The amount fits common daily cognitive use.

Ginkgo may support selected memory, focus, or circulation-related outcomes, but it is not a broad nootropic. Its vision relevance is also narrow because it does not supply lutein, zeaxanthin, retinal omega-3 fats, or antioxidant minerals.

Both marker groups are named, but their percentages and a low-ginkgolic-acid standard are absent. The focused format is easy to understand, though extract quality matters more than raw leaf weight or package size.

Who is it for
  • Adults seeking focused ginkgo supplementation
  • Users interested in circulation-related cognitive support
  • People who prefer a capsule
Best for
  • Targeted ginkgo use
  • Memory and focus routines in suitable adults
  • Users seeking a single-botanical formula

Pros

  • Ginkgo amount is clearly listed
  • Focused formula is easy to assess
  • Amount fits common daily use
  • Stimulant-free botanical

Cons

  • Does not provide broad cognitive pathway coverage
  • Not a complete vision formula
  • Benefits remain situation-dependent
  • No complementary nutrients are included

Warnings

  • Ginkgo may add to warfarin, direct oral anticoagulants, aspirin, or other antiplatelet effects and increase bleeding risk
  • Stop ginkgo before surgery or an invasive procedure when directed by the treating clinician because of its bleeding effects
  • Ginkgo may cause headache, dizziness, or digestive upset in sensitive users

Nutrient quality

89 Highest impact

The meaningful amount and named marker groups support the intended use. Missing exact percentages and purity limits reduce confidence despite the focused design.

.

Ingredient transparency

81 Highest impact

Active amounts and marker names are disclosed without a hidden blend. Exact standardization, daily-use directions, and non-active ingredients remain unavailable.

.

Customer satisfaction

71 High impact

The available rating is strong and the sample is very large. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

97 Highest impact

A meaningful extract amount and very long supply deliver excellent practical value. The focused formula avoids extras, with purity documentation as the main limitation.

.
Report analysis

Goals

Productivity Boost
Productivity Boost
Impact
High effect
B Goal FitB Strength of SupportD+ CoverageA+ Formula Quality

Ginkgo may support mental clarity and circulation at a clinically aligned amount. Its evidence is stronger for age-related cognitive concerns than for immediate productivity in healthy adults.

Active marker classes are named, but percentages and a low-ginkgolic-acid purity limit are not disclosed. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Mental Focus
Impact
High effect
C Goal FitA- Strength of SupportC- CoverageA+ Formula Quality

Standardized ginkgo may support cerebral circulation, processing speed, and attention, with the clearest relevance in older adults. Human findings for focus in healthy people are mixed, so it is less dependable than established acute nootropics.

The 120 mg amount reaches a commonly used starting dose, and flavone glycosides plus terpene lactones are identified. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, especially around surgery.

Study evidence
Ginkgo Supportive 28 studies
Brain Health
Brain Health
Impact
High effect
B Goal FitB- Strength of SupportD+ CoverageB+ Formula Quality

Ginkgo offers targeted cerebral-circulation support that may benefit selected users. Evidence is more applicable to older adults or impaired cognition than to healthy young adults.

The 120 mg extract amount is practical, but active-marker percentages and a low-ginkgolic-acid standard are absent. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
High effect
B Goal FitB- Strength of SupportD+ CoverageB+ Formula Quality

Ginkgo offers targeted cerebral-circulation support that may benefit selected users. Evidence is more applicable to older adults or impaired cognition than to healthy young adults.

The 120 mg extract amount is practical, but active-marker percentages and a low-ginkgolic-acid standard are absent. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Vision Support
Vision Support
Impact
High effect
D+ Goal FitA Strength of SupportD- CoverageA Formula Quality

Standardized ginkgo extract may support ocular circulation, but it is not a core macular pigment or structural eye nutrient. Human evidence for routine vision support is limited and condition-specific.

Flavone glycosides and terpene lactones are identified with a substantial extract amount. Ginkgo may increase bleeding risk when combined with antiplatelet or anticoagulant medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones)
 120 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
Ginkgo (Ginkgo Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore48
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The extract supplies a practical daily amount, but the label data does not state the percentages of its two key active markers. No ginkgolic acid limit or recognized purified extract is identified, leaving an important quality gap. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
81 Value

Extra Strength Ginkgo 120 mg

Doctor's Best
A lower serving cost than the original accompanies the following trade-off: a low serving cost provides 120 mg of ginkgo extract identified by flavonol glycosides and terpene lactones. Marker percentages and a ginkgolic-acid limit are not provided, but the single-ingredient design is easy to compare.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A higher serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  4. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  5. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  6. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials.
    Feng JX; Zheng MQ; Tian X; Zimmermann A; Wang AX; Meng X · Frontiers in neurology · 2026
    Meta-analysis488 participants4 studies pooledBrain Health forGinkgo
  8. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  9. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  10. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  11. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsMental Focus Productivity Boost forGinkgo
  12. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence.
    Sarris J; Kean J; Schweitzer I; Lake J · Complementary therapies in medicine · 2012
    Systematic review16 studies pooledMental Focus forGinkgo
  13. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  14. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  15. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  16. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  17. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  18. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  19. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  20. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  21. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  22. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  23. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  24. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  25. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  26. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  27. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  28. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  29. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  30. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  31. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  32. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  33. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  34. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo